750360
Last Update Posted: 2018-11-06
Recruiting has ended
All Genders accepted | 6 months + |
883 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
Study to Monitor the Safety and Reactogenicity of Fluarix™ in Korean Subjects Aged > 6 Months of Age.
The present study collects data on safety and reactogenicity of the vaccine in the local target population (600 or more subjects) as per the requirement of Korean Food and Drugs Administration (KFDA).
Eligibility
Relevant conditions:
Influenza
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov